# Macrogenics (MGNX) — Earnings

MGNX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mgnx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.57 |
| EPS estimate | −$0.42 |
| EPS surprise | −34.66% |
| Revenue surprise | −29.77% |
| Revenue | $22.2M |
| Revenue estimate | $31.7M |
| Reported | Aug 14, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1125345/000112534525000101/mgnx-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 14, 2025 | −$0.42 | −$0.57 | -34.66% | $31.7M | $22.2M |
| Q1 2025 | May 13, 2025 | −$0.73 | −$0.65 | 10.43% | $9.6M | $13.2M |
| Q4 2024 | Mar 20, 2025 | −$0.28 | −$0.24 | 13.92% | $35.7M | $19.4M |
| Q3 2024 | Nov 5, 2024 | $0.21 | $0.90 | 325.53% | $87.6M | $110.7M |
| Q2 2024 | Aug 6, 2024 | −$0.66 | −$0.89 | -34.66% | $20.9M | $10.8M |
| Q1 2024 | May 9, 2024 | −$0.64 | −$0.84 | -30.72% | $14.9M | $9.1M |
| Q4 2023 | Mar 7, 2024 | −$0.15 | −$0.74 | -382.08% | $32.6M | $10.7M |
| Q3 2023 | Nov 6, 2023 | −$0.10 | $0.28 | 393.81% | $50.9M | $10.4M |
| Q2 2023 | Aug 9, 2023 | −$0.52 | $0.92 | 276.58% | $29.2M | $13.1M |
| Q1 2023 | May 9, 2023 | $0.45 | −$0.61 | -234.84% | $96.2M | $24.5M |
| Q4 2022 | Mar 15, 2023 | $0.10 | $0.21 | 104.70% | $64.4M | $73.1M |
| Q3 2022 | Nov 3, 2022 | −$0.38 | −$0.40 | -4.28% | $29.3M | $41.7M |
| Q2 2022 | Aug 8, 2022 | −$0.98 | −$0.67 | 31.56% | $14.2M | $26.0M |
| Q1 2022 | May 3, 2022 | −$0.85 | −$1.08 | -27.22% | $23.2M | $11.1M |
| Q4 2021 | Feb 24, 2022 | −$0.81 | −$0.95 | -16.59% | $22.8M | $14.1M |
| Q3 2021 | Nov 2, 2021 | −$0.71 | −$0.86 | -21.04% | $34.0M | $15.7M |
| Q2 2021 | Jul 29, 2021 | −$0.46 | −$0.66 | -44.90% | $32.1M | $30.8M |
| Q1 2021 | Apr 29, 2021 | −$0.64 | −$0.90 | -41.00% | $26.2M | $16.9M |
| Q4 2020 | Feb 25, 2021 | −$0.73 | $0.04 | 105.49% | $26.0M | $52.7M |
| Q3 2020 | Nov 4, 2020 | −$0.93 | −$0.66 | 29.09% | $14.0M | $18.3M |

## Frequently Asked Questions

### When did Macrogenics (MGNX) last report earnings?

Macrogenics last reported on Aug 14, 2025, covering fiscal Q2 2025.

### Did MGNX beat earnings estimates?

No. Macrogenics reported EPS of −$0.57 for Q2 2025 against a −$0.42 estimate — a 34.66% miss.

### How much revenue did MGNX report last quarter?

Macrogenics reported $22.2M in revenue for Q2 2025, against a consensus estimate of $31.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).